US 10279015
TPP-1 formulations and methods for treating CLN2 disease
granted A61KA61K38/4813A61K47/02
Quick answer
US patent 10279015 (TPP-1 formulations and methods for treating CLN2 disease) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/4813, A61K47/02, A61K9/0048, A61K9/0085